SLC2A1 and cancer: LSH can aggravate cancer due to its ability of inhibit ferroptosis via the activation of metabolism-related genes as solute carrier family 2 member 1 (SLC2A1/GLUT1) and FADS2 both in vitro and in vivo (Jiang et al., 2017; Yang et al., 2019).